-
Pfizer And Medivation: A Good Strategic Fit
Post on 8/26/16
-
Forbes Magazine Names Incyte to its List of World’s Most Innovative Companies for Second Consecutive Year
Post on 8/25/16
-
Bracket Expands North American Presence with New Boston Location
Post on 8/25/16
-
Dear Pfizer, Stop Overpaying for Acquisitions!
Post on 8/25/16
-
Ethicon Announces Strategic Collaboration With Touch Surgery
Post on 8/24/16
-
Reproductive Medicine Associates of New Jersey Offers Free AMH Fertility Screening at South Jersey Location
Post on 8/24/16
-
Biothera Pharmaceuticals Expands Relationship with Merck
Post on 8/24/16
-
What Pfizer Gets in Its $14 Billion Medivation Deal
Post on 8/24/16
-
Asana BioSciences Relocates to the Princeton Area in New Jersey
Post on 8/23/16
-
Dune Medical Devices Awarded Prestigious Grant to Bring Biopsy System to Market
Post on 8/23/16
-
Rite Aid’s RediClinic and Hackensack Meridian Health Form Joint Venture
Post on 8/23/16
-
Hemispherx Biopharma Announces Major Breakthrough
Post on 8/23/16
-
Johnson & Johnson Could Become the First Company to Reach a $1 Trillion Valuation
Post on 8/23/16
-
Arno Therapeutics Reports Q2 2016 Financial and Business Update
Post on 8/22/16
-
Pfizer To Acquire Medivation
Post on 8/22/16
-
Johnson & Johnson: Grim Future Dividend Outlook Means Shares Are Overvalued Right Now
Post on 8/22/16
-
3 Reasons Medivation Is the Juiciest Target in Biotech
Post on 8/22/16
-
Here's the Best Dividend Stock in Big Pharma
Post on 8/22/16
-
This University City Startup Wants To Streamline Clinical Trials
Post on 8/21/16
-
CBCF And Bloomindale’s At The Mall At Short Hills Team Up For Fashion Forward Evening To Benefit Breast Cancer Research
Post on 8/19/16
-
Hemispherx Biopharma Forms Scientific Advisory Board
Post on 8/19/16
-
Why I Hate Johnson & Johnson Right Now (But I'll Never Sell)
Post on 8/19/16
-
TandemLife Named as Finalist for Pittsburgh Technology Council's Tech 50 Innovator of the Year Award
Post on 8/18/16
-
Pinnacle Foods to Relocate EVOL Frozen Foods Production
Post on 8/18/16
-
Symbiomix Therapeutics Accelerates Commercial Launch Preparation for Solosec
Post on 8/18/16
Philadelphia
